Jade Biosciences, Inc. (JBIO) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...
Investing.com - BTIG reiterated a Buy rating and $28.00 price target on Jade Biosciences (NASDAQ:JBIO) on Friday. The stock currently trades at $14.11, representing 55% upside to BTIG’s target.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results